Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Array Biopharma, Inc.
(NQ:
ARRY
)
5.890
USD
+0.200 (+3.51%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about Array Biopharma, Inc.
Biotech Stocks to Watch (QCOR, ARRY, NBS, NKTR, FOLD)
February 06, 2013
Las Vegas, NV -- (SBWIRE) -- 02/06/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by Beststocksdaily.
Read More
from
SBWire - Latest Press Releases
Baidu.com, Inc. (ADR) (NASDAQ:BIDU) Under Pressure After Earnings: ACLS, APKT, ARRY, BIDU
February 05, 2013
Lakeway, NY -- (SBWIRE) -- 02/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Top Stocks to Watch: ARNA, ARRY, ACTV, ARAY, ZUMZ
November 30, 2012
Las Vegas, NV -- (SBWIRE) -- 11/30/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by Beststocksdaily....
Read More
from
SBWire - Latest Press Releases
Biggest Percent Losers (KTOS, TRLA, ARRY, CECO)
November 12, 2012
New York, NY -- (SBWIRE) -- 11/12/2012 -- PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We...
Read More
from
SBWire - Latest Press Releases
PennyStocks101 Reports 5 Stocks with Big Declines on Friday: Groupon Inc., Nutrisystem Inc., Array Biopharma Inc., Walt Disney Company, and J.C. Penney Company Inc. Holding Company
November 10, 2012
Beverly Hills, CA -- (SBWIRE) -- 11/10/2012 -- http://www.PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States...
Read More
from
SBWire - Latest Press Releases
Today's Market Winners and Losers (AMRN, ISIS, ARRY, MTG)
November 09, 2012
Los Angelas, CA -- (SBWIRE) -- 11/09/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
NASDAQ Bleed On Q3 (GRPN, MDRX, ARRY, CPRX, PGRX)
November 09, 2012
New York, NY -- (SBWIRE) -- 11/09/2012 -- TooNiceStocks.com - Sign up for weekly Technical and Equity Research Reports covering all equity sectors. We have a proven track record, please come visit and...
Read More
from
SBWire - Latest Press Releases
Singles Only: 3 Low-Priced Stocks for Your Portfolio
October 11, 2012
Three strong names uncovered in this week's Singles Only search for low-priced trade candidates are Array Biopharma Inc (NASDADQ:ARRY), Global Cash Access Holdings, Inc...( Read More )
Read More
category
ARRY
from
SchaeffersResearch.com Daily Market Blog
Should Buying This Stocks Right Now? ( ATRS, DARA, ARRY, UDRL )
September 26, 2012
Los Angelas, CA -- (SBWIRE) -- 09/26/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
Sell High-Beta Small Cap Stocks
August 16, 2012
category
Stock/Screens
,
Stock/Picks/2012/Q3
,
Stock/Picks
, and 4 more.
from
Wall Street Greek
SmallCapNewsRelease: (OTCBB: IMUN) Announces New Corporate Website, IMUN.com
July 30, 2012
Jericho, NY -- (SBWIRE) -- 07/30/2012 -- Immunovative, Inc. (OTCBB: IMUN) announced earlier today the launch of their corporate website, imun.com as well as ImmuNews, the company's new monthly...
Read More
from
SBWire - Latest Press Releases
Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials
May 17, 2012
While Wall Street can't seem to shake its euro-zone anxiety, it's some disappointing domestic data that's amplified the bearish mood on the major market indexes this afternoon...( Read More )
Read More
category
ARRY
from
SchaeffersResearch.com Trading Floor Blog
2012 ASCO Conference Stocks
April 20, 2012
Analyst Ian Cooper takes a look at some of the top presenters at this year's 2012 ASCO conference and offers a few ways to trade the event.
Read More
from
Wealth Daily
Standard and Poor’s Worst Mistake Yet
August 08, 2011
category
Week/Ahead
,
Rating/Agencies
,
Editors/Picks
, and 1 more.
from
Wall Street Greek
Skype IPO S-1 Registration with SEC
August 10, 2010
from
Wall Street Greek
This Week: FOMC, International Trade, Retail Sales Key
August 10, 2010
from
Wall Street Greek
Stock Market Schedule May 3 - 7
May 04, 2010
from
Wall Street Greek
Top After-Hours Earnings (May 3)
May 03, 2010
» Look for the following companies to release earnings After the Close today – Monday, May 3: Company EPS EST Revenue Estimate Actuate (ACTU) 0.06 0.1 $29.1 mln $32.6 mln AirMedia Group (AMCN) -0.10...
Read More
category
earnings
,
Wall Street
,
Business
from
Wall Street Pit
(ARRY) Array BioPharma and Novartis AG Sign Deal for Treating Cancer
April 22, 2010
Recently, Array BioPharma Inc. (ARRY) struck a deal with Novartis AG (NVS) to develop its small-molecule methyl ethyl ketone (MEK) inhibitors for treating cancer. The transaction is worth up to $467...
Read More
category
AZN
,
CELG
,
Novartis AG
, and 9 more.
from
Stock Blog Hub
Array And Novartis Ink Deal
April 22, 2010
Recently, Array BioPharma Inc. (NASDAQ:ARRY) struck a deal with Novartis AG (NYSE:NVS) to develop its small-molecule methyl ethyl ketone (MEK) inhibitors for treating cancer. The transaction is worth...
Read More
category
AZN
,
CELG
,
External Research
, and 7 more.
from
DailyMarkets.com
Market Shows Resiliency in Up-Session
April 20, 2010
The stock market indices started out with a pop from the get-go with strong futures, then rolled over hard early on, held support, and rallied sharply to new snapback rally highs, reaching as high as...
Read More
from
Harry's Hotline by Harry Boxer
13 Gainers To Watch Out - 20th April
April 20, 2010
from
Small Cap Bear...
(ARRY) Array BioPharma Incorporated Reports Lower Second Quarter Loss
February 02, 2010
Array BioPharma Inc’s (ARRY) second quarter fiscal 2010 net loss came in at $21.8 million, or 44 cents per share, which was lower than the Zacks Consensus Estimate of a net loss of 55 cents. The...
Read More
category
Healthcare
,
Array BioPharma
,
Medical Laboratories & Research
, and 1 more.
from
Stock Blog Hub
Lower Q2 Loss For Array Bio
February 02, 2010
Array BioPharma Inc’s (ARRY) second quarter fiscal 2010 net loss came in at $21.8 million, or 44 cents per share, which was lower than the Zacks Consensus Estimate of a net loss of 55 cents. The...
Read More
category
USA
,
Stocks
,
External Research
, and 3 more.
from
DailyMarkets.com
Federal Budget et al 02-01-10
February 01, 2010
from
Wall Street Greek
(ARRY) Array BioPharma Sees Positive Results for ARRY-380
December 14, 2009
Recently, Array BioPharma Inc. (ARRY) announced positive interim results on its inhibitor, ARRY-380, from an early-stage, open-label, multiple dose trial in patients with advanced cancer. The company...
Read More
category
ArQule Inc
,
Vertex Pharmaceuticals Incorporated
,
Medical Laboratories & Research
, and 5 more.
from
Stock Blog Hub
(ARRY) Setback for Array BioPharma’s Drug
September 08, 2009
Last week, Array BioPharma (ARRY) announced that its most advanced, wholly-owned MEK inhibitor, ARRY-162, which was being developed to treat rheumatoid arthritis patients, failed to achieve a better...
Read More
category
AZN
,
CELG
,
Medical Laboratories & Research
, and 5 more.
from
Stock Blog Hub
(ARRY) Array Meets Expectations
August 20, 2009
Last week, Array BioPharma Inc. (ARRY) reported a fourth-quarter net loss of 55 cents per share which was in line with the Zacks Consensus Estimate. The company had a loss of 68 cents in the year-ago...
Read More
category
AZN
,
CELG
,
Array BioPharma, Inc/
, and 5 more.
from
Stock Blog Hub
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here